Long Term Follow-up After Embolization of Brain Arteriovenous Malformations

The time-frame and the follow-up elements after embolization of brain arteriovenous malformations are not standardized. Therefore, few reliable follow-up data are available for these patients. This study aims at collecting standardized long term data for these patients.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Arteriovenous Malformations Cardiovascular Abnormalities Cardiovascular Diseases Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Vascular Diseases Vascular Malformations

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondation Ophtalmologique Adolphe de Rothschild

Paris, 75019, France

Location status: Recruiting

Location contact

Raphaël Blanc, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

arteriovenous malformation
age > 18 years old

Exclusion criteria

none

Treatment and study plan

Primary outcomes

angiographic evaluation of the arteriovenous malformation occlusion

Time frame: 5 years after embolization

Study contacts

Contact information is provided by the study sponsor or research team.

Amélie Yavchitz, MD

CONTACT

[email protected]

+33 1 48 03 64 54

Sponsors and collaborators

Lead sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Network

Registry information

Acronym: MAV-endovasc

Important dates

Study start: 2015
Primary completion: 2037
Study completion: 2037
First posted: Aug 25, 2016
Registry last updated: Jan 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting